Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

1

About Gil Shklarski

Gil Shklarski is an angel investor based in New York, New York.

Gil Shklarski Headquarter Location

New York, New York,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Gil Shklarski News

NeuraLight appoints Dr. Gil Shklarski as Scientific Co-founder and Board Observer

Jan 16, 2022

NeuraLight appoints Dr. Gil Shklarski as Scientific Co-founder and Board Observer Before joining NeuraLight, Dr. Shklarski served as CTO of Flatiron Health, a healthtech company focused on cancer treatment and research James Spiro 10:2316.01.22 NeuraLight, a company that digitizes neurological insights using AI, has announced that it has added Gil Shklarski, Ph.D. as Scientific Co-founder and Board Observer. In his new role, Dr. Shklarski will help the company with its next phase of growth as it evolves from Seed to a Series A round. “Having been an early investor in NeuraLight from the start, I’ve been impressed with the quality of people the company has brought on and the velocity in tech, clinical, and commercial discovery they’ve had in the last year,” said Dr. Shklarski. “I decided to join as an integral part of the team because I truly believe the team and technology have the potential to transform the lives of people with neurological disorders, and I look forward to helping implement this technology in clinical trials at the commercial level.”     Before joining NeuraLight, Dr. Shklarski served as CTO of Flatiron Health, a healthtech company focused on cancer treatment and research, which was acquired by Roche for $1.9 billion. While there, he oversaw software engineering, information security, data insight engineering, and product design functions. Before Flatiron, he built data processing systems for Microsoft, Facebook, and the Israel Defense Forces, both as a developer and a manager. “Adding Gil to our team is one of those rare inflection points that will change the trajectory of our company for years to come,” added Dr. Micha Breakstone, CEO and Co-founder of NeuraLight. “Gil is not only one of the most brilliant operators we've worked with, but one of the most dedicated and thoughtful ones, and having Gil’s expertise in the digital health space will be invaluable as we drive forward into 2022.” Related Stories: Dr. Shklarsi has been involved with NeuraLight for more than four years, starting his involvement as an investor and advisor. He has worked with the company’s CTO and Co-Founder, Eddy Ben-Ami in the space of signal processing for 20 years and will help NeuraLight leverage proprietary Computer Vision and Deep Learning technology. NeuraLight launched from stealth in October 2021 with the announcement of a $5.5 million investment co-led by MSAD.vc, Kli Capital, and Tuesday Capital. Its AI-driven platform integrates digital markets to accelerate and improve drug development, monitoring, and precision care for patients with neurological disorders. Dr. Shklarski currently serves as General Partner at Operator Partners and at NeuraLight and will work closely with management to define the strategic playbook and execute the commercial aspects as the company launches its first clinical trials.

Gil Shklarski Investments

1 Investments

Gil Shklarski has made 1 investments. Their latest investment was in RightBound as part of their Series A on May 5, 2021.

CBI Logo

Gil Shklarski Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/26/2021

Series A

RightBound

$12M

Yes

12

Date

5/26/2021

Round

Series A

Company

RightBound

Amount

$12M

New?

Yes

Co-Investors

Sources

12

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.